Welcome to our dedicated page for XBP Global Holdings SEC filings (Ticker: XBP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
XBP Global Holdings, Inc. filings document the company’s public-company governance, capital structure and material events as a Nasdaq-listed workflow automation and technology services issuer. Proxy materials cover board elections, auditor ratification, advisory executive-compensation votes and say-on-pay frequency matters, while event filings address operating and financial results.
Form 8-K disclosures record material agreements and amendments involving XBP Americas credit arrangements, charter-related corporate actions, Nasdaq listing compliance notices and registered securities. The filing record also identifies XBP common stock and redeemable warrants, related exchange listings, governance matters, risk disclosures and security-structure information.
XBP Global Holdings, Inc. reported insider equity activity for Chief Financial Officer Dejan Avramovic. He received a grant of 32,500 shares of common stock as a stock-based award, bringing his direct holdings to 85,235 shares after the transaction.
A prior transaction on February 13, 2026 involved 3,006 shares withheld at $7.73 per share to cover tax obligations tied to the vesting of a previously reported Restricted Stock Unit (RSU) award. The new RSUs were issued under the 2024 Stock Incentive Plan and vest in three equal installments on December 31 of 2026, 2027, and 2028, and are settled in stock only.
XBP Global Holdings is asking stockholders to vote on four key items at its virtual 2026 annual meeting. Investors will elect seven directors to one-year terms, ratify UHY LLP as auditor for 2026, approve an advisory say-on-pay resolution, and choose how often future say-on-pay votes occur, with the board recommending every one year.
The record date is April 21, 2026, when 11,768,050 common shares were outstanding, each with one vote. XBP explains recent corporate restructuring that created distinct Predecessor and Successor reporting periods in 2025 and shifted it from controlled-company status to a majority-independent board. The proxy also details director and executive pay, including cash retainers, restricted stock units, and a performance-based bonus plan tied to revenue and adjusted EBITDA.
XBP Global Holdings, Inc. describes its 2025 operations as a multinational technology and services company that powers intelligent, AI-driven workflows for more than 2,500 clients across highly regulated sectors such as healthcare, banking, insurance and the public sector.
For 2025 the Predecessor period from January 1 to July 31 generated $431.7 million of revenue and the Successor period from August 1 to December 31 generated $359.4 million, with about 90% of combined revenue from the United States. Healthcare contributed about 28% of 2025 revenue, banking and financial services 19%, and public sector work 11%.
The report explains the July 29, 2025 Business Combination in which XBP acquired BPA, which had just emerged from Chapter 11 reorganization, creating a global platform spanning the Americas, EMEA and Asia. It also notes a one-for-ten reverse stock split completed on December 12, 2025, leaving 11,768,050 common shares outstanding as of March 30, 2026.
Management highlights a strategic focus on agentic AI, robotic process automation, digital mailroom, workflow automation, and industry-specific platforms such as PCH Global for healthcare revenue cycle management and the XBP exchange for bills and payments. As of December 31, 2025 the company had about 10,600 employees in 20 countries and relatively low client concentration, with its top five clients accounting for 27% of 2025 revenue and no single client exceeding 10%.
XBP Global Holdings, Inc. reported fourth quarter and full year 2025 results reflecting a major transition after acquiring Exela Technologies BPA. As reported full year 2025 revenue was $791.0 million, down from $872.7 million, while pro forma revenue was $879.6 million versus $1,017.6 million. As reported full year gross margin held near 21.7%, and pro forma gross margin was 21.9%. Fourth quarter 2025 revenue was $207.0 million, down 15.1% year over year, with gross margin improving to 22.7%. The company recorded a successor-period net loss of $351.1 million, driven largely by a $320.3 million goodwill impairment, while full year pro forma normalized EBITDA reached $90.2 million. Management highlighted sales investments and agentic AI-driven automation aimed at stabilizing the acquired business and supporting future growth.
XBP Global Holdings, Inc. disclosed that subsidiary XBP Americas, LLC entered into a Limited Waiver and Third Amendment to its asset-based Credit and Security Agreement on March 6, 2026. The amendment removes the covenant requiring minimum excess availability of $7.5 million.
The Third Amendment adds a temporary availability block through June 30, 2026, reducing borrowing capacity by the greater of $3.75 million or 5.0% of the borrowing base if the fixed charge coverage ratio falls below 1.00 to 1.00. It also temporarily raises the advance rate on eligible investment grade billed accounts to 95.0% through September 30, 2026 and adjusts borrowing base calculations, cash dominion mechanics, and the deferred revolving loan origination fee.
XBP Global Holdings, Inc. filed a new Certificate of Amendment to its Third Amended and Restated Certificate of Incorporation with the Delaware Secretary of State on December 12, 2025, and also filed two Certificates of Correction that void earlier charter amendments from July 29 and July 30, 2025.
The company explains that these corrective filings do not change the substance of its charter or its previously announced plans regarding its common stock, but instead replace the July 29 amendment and void a July 30 amendment that had purported to change the company’s name to a name change already in effect.
XBP Global Holdings (XBP) filed its Q3 2025 report reflecting fresh start accounting after acquiring Exela Technologies BPA and emerging from Chapter 11 on July 29, 2025. The Successor period (Aug 1–Sep 30, 2025) shows revenue of $152.4 million and a net loss of $305.8 million, driven by a $295.8 million goodwill impairment.
As of September 30, 2025, total assets were $947.9 million and total liabilities were $817.4 million, resulting in stockholders’ equity of $130.5 million. Cash and cash equivalents were $34.5 million with an additional $29.7 million of restricted cash. Long‑term debt (net of current) was $346.6 million, and current portion of long‑term debt was $34.9 million.
The company now reports two segments: Applied Workflow Automation and Technology. In the Successor period, the U.S. generated $123.4 million of total revenue. Post‑restructuring ownership is dispersed; as of September 30, 2025 ETI held approximately 29.1%, Gates Capital Management approximately 25.7%, and Avenue Capital approximately 9.8%, in each case, assuming the exercise of all warrants held by the Consenting ETI Parties. Common shares outstanding were 117,515,972.
Howard W. Lutnick, a director of XBP Global Holdings, Inc. (XBP), reported on 10/06/2025 the disposition of indirect holdings tied to CFAC Holdings VIII, LLC. As trustee, he closed the sale of the voting shares of CF Group Management, Inc. (CFGM) that previously gave indirect control over CFAC, which directly owned 6,064,404 shares of common stock and warrants underlying 385,000 common shares exercisable within 60 days.
Following the transaction, the reporting person no longer beneficially owns those CFAC-held shares. The aggregate sale price for the voting shares of CFGM was $200,000. The filing disclaims any remaining beneficial ownership beyond any pecuniary interest.
XBP Global Holdings (XBP) filed a Form 3 disclosing a director’s initial beneficial ownership. The reporting person indirectly holds 6,064,404 shares of common stock through CFAC and warrants for 385,000 shares at an exercise price of $11.5, expiring 12/29/2028 and exercisable within 60 days. On October 6, 2025, trusts he controls closed the purchase of all voting shares of CFGM for $200,000, which may result in deemed beneficial ownership of CFAC’s holdings.